Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-25-049297
Filing Date
2025-04-02
Accepted
2025-04-02 16:05:23
Documents
1
Period of Report
2025-01-30

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 7204
  Complete submission text file 0000950170-25-049297.txt   8638
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Issuer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BEAM THERAPEUTICS INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Evans John M. (Reporting) CIK: 0001786304 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39208 | Film No.: 25804323